[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334312-105":59,"doc-detail-334312-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","long-term-survival-of-a-kidney-transplant-patient-with-advanced-renal-cancer-after-combination-therapy-a-case-report-and-literature-review","Long-term survival of a kidney transplant patient with advanced renal cancer after combination therapy - a case report and literature review","","De novo renal transplant carcinoma, particularly with bilateral renal carcinoma, is rare and often manifests as small, low-grade papillary renal cell carcinoma. No consensus exists for advanced metastatic RCC treatment after kidney transplantation. A 40-year-old man developed de novo transplant carcinoma 13 years post-transplant with venous thrombus and lung metastases. He received cytoreductive nephrectomy plus sequential tyrosine kinase inhibitors and anti-PD-1 therapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/long-term-survival-of-a-kidney-transplant-patient-with-advanced-renal-cancer-after-combination-therapy-a-case-report-and-literature-review/334312/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/long-term-survival-of-a-kidney-transplant-patient-with-advanced-renal-cancer-after-combination-therapy-a-case-report-and-literature-review/334312.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What makes this kidney transplant-related cancer case unusual?","Question",{"text":113,"@type":114},"De novo renal transplant carcinoma in the setting of bilateral renal carcinoma is rare. The patient also developed venous thrombus and lung metastases 13 years after transplantation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the metastatic disease diagnosed?",{"text":118,"@type":114},"Contrast-enhanced CT and PET-CT showed bilateral malignant renal masses, tumor thrombi, adrenal/vertebral involvement, ischial metastases, and abdominal lymphadenopathy. Chest CT revealed multiple lung nodules, and biopsy confirmed poorly differentiated clear cell RCC.",{"name":120,"@type":111,"acceptedAnswer":121},"What treatment sequence was used and what was the outcome?",{"text":122,"@type":114},"The patient underwent cytoreductive nephrectomy and removal of tumor thrombi, followed by sequential tyrosine kinase inhibitors and anti-PD-1 monoclonal antibodies. After 2 years, graft function was excellent with no evidence of cancer progression, and overall survival exceeded typical ranges reported for advanced disease.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334312,1790193402,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Long-term survival of a kidney transplant patient with advanced renal cancer after combination therapy: a case report and literature review  \nChao Peng 1,*, Weihao Wang 1,*, Jiajun Chen 1 , Shouhua Pan 1 , Gang Xu 1 , Mengyao Li2, Lulu Zhang3, Yulei Li 1, Keyuan Zhao 1 and Jing Jin 1  \nJournal of International Medical Research 2024, Vol. 52(12) 1–8! The Author(s) 2024 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03000605241304640](DOI: 10.1177/03000605241304640)[ ](DOI: 10.1177/03000605241304640)[journals.sagepub.com/home/imr](journals.sagepub.com/home/imr)  \nAbstract  \nDe novo renal transplant carcinoma, especially in the context of bilateral renal carcinoma, is rare and often presents as small, low-grade papillary renal cell carcinoma (RCC). There is currently no consensus or effective treatment for advanced metastatic RCC after kidney transplantation. A 40-year-old man developed de novo renal transplant carcinoma with venous thrombus and lung metastases 13 years after transplantation. The patient underwent cytoreductive nephrectomy followed by sequential treatment with tyrosine kinase inhibitors (TKI) and anti-PD-1 monoclonal antibodies. After 2 years, the patient showed excellent graft function with no evidence of cancer progression. Despite subsequent graft failure, the disease remained controlled for more than 2 years and the patient survived for more than 3 years, which was significantly longer than the typical survival of 10 to 20 months in patients with advanced kidney cancer. The results suggest that combining cytoreductive nephrectomy with TKI and anti-PD-1 therapy may significantly prolong survival in patients with renal allograft carcinoma.  \n1 Department of Urology, Shaoxing People’s Hospital, Shaoxing, Zhejiang, China  \n2Department of Pathology, Shaoxing People’s Hospital, Shaoxing, China  \n3Department of Medical Research Center, Shaoxing People’s Hospital, Shaoxing, China  \n*These authors contributed equally to this work. Corresponding author:  \nJiajun Chen, Department of Urology, Shaoxing People’s Hospital, No. 568 Zhongxing North Road, Yuecheng District, Shaoxing City, Zhejiang Province, Shaoxing 312000, China.  \nEmail: [17858515899@163.com](17858515899@163.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative  \nCommons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \nKeywords  \nRenal carcinoma, renal transplantation, cytoreductive nephrectomy, targeted therapy, immunotherapy, survival  \nDate received: 26 July 2024; accepted: 14 November 2024  \nBackground  \nThe incidence of renal cell carcinoma (RCC) among kidney transplant recipients has increased as a result of long-term immunosuppression therapy. Solid organ tumors, lymphomas, and skin non-melanoma were reported in 10.8% of patients who received a renal transplant, with renal and lung cancers being the most common solid malignancies.1 Most RCCs detected in transplant recipients are de novo neoplasms in the native kidney; however, RCCs can also emerge in the donor kidney as recessive tumors present in the donor organ prior to transplantation.2,3 A lack of relevant studies means that the systemic treatment of metastatic RCC after renal transplantation poses a challenge, and objective treatment evaluations are necessary to address this issue. The current case report outlines the various therapeutic options that have been demonstrated to yield favorable short-term outcomes in renal transplant recipients diagnosed with ","cbCaihoCjg5KZIVO","https://ap.wps.com/l/cbCaihoCjg5KZIVO","pdf",1650168,"English","# Abstract\n# Background\n# Case presentation","[{\"question\":\"What makes this kidney transplant-related cancer case unusual?\",\"answer\":\"De novo renal transplant carcinoma in the setting of bilateral renal carcinoma is rare. The patient also developed venous thrombus and lung metastases 13 years after transplantation.\"},{\"question\":\"How was the metastatic disease diagnosed?\",\"answer\":\"Contrast-enhanced CT and PET-CT showed bilateral malignant renal masses, tumor thrombi, adrenal/vertebral involvement, ischial metastases, and abdominal lymphadenopathy. Chest CT revealed multiple lung nodules, and biopsy confirmed poorly differentiated clear cell RCC.\"},{\"question\":\"What treatment sequence was used and what was the outcome?\",\"answer\":\"The patient underwent cytoreductive nephrectomy and removal of tumor thrombi, followed by sequential tyrosine kinase inhibitors and anti-PD-1 monoclonal antibodies. After 2 years, graft function was excellent with no evidence of cancer progression, and overall survival exceeded typical ranges reported for advanced disease.\"}]","Long-term survival of a kidney transplant patient with advanced renal cancer after combination therapy - a case report and literature review | PDF",1790006229]